HOME >> MEDICINE >> NEWS
Targeted therapy shows significant benefits over standard treatment for advanced kidney cancer

ATLANTA According to a new study, the drug sunitinib malate (Sutent) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC). The study is being presented today at the annual American Society of Clinical Oncology meeting.

"This drug has shown more activity as a single agent against advanced kidney cancer than any other drug I've studied in the past 15 years," said the study's lead author Robert J. Motzer, MD, a medical oncologist at Memorial Sloan-Kettering Cancer Center (MSKCC). "I continue to be encouraged by its effectiveness in treating patients with this aggressive disease," said Dr. Motzer, who is a leader in the treatment of kidney cancer and conducted the earliest clinical trials on sunitinib (initially referred to as SU11248).

Interferon-alpha (IFN-) is one of the standard treatments for advanced kidney cancer, however only about 15 percent of patients respond to this immunotherapy. Sunitinib targets receptors on kidney cancer cells that may play a role in tumor growth and the development of blood vessels that feed a tumor. Previous clinical trials, also led by Dr. Motzer, showed that sunitinib caused some renal cell cancers to shrink, but this study is the first to demonstrate its effectiveness as a first-line therapy compared with standard cytokine therapy with IFN-.

The current randomized trial included 750 patients over the age of 60, half of whom were treated with a six-week cycle of sunitinib and half of whom were treated with a six-week cycle of the current treatment standard, IFN-. The primary endpoint of the trial was a comparison of progression-free survival between sunitinib and IFN- as assessed by independent third-party review. The median progression-free survival for treatment with sunitinib was 11 months, compared with 5 months following treatment with IFN-. This outcome was statistical
'"/>

Contact: Maria Connizzo
mediastaff@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
4-Jun-2006


Page: 1 2

Related medicine news :

1. Targeted, oral agent Enzastaurin shows favorable results
2. Targeted initiatives can encourage people to walk more
3. Targeted nanoparticles incorporating siRNA offer promise for cancer treatment
4. Targeted cancer drugs may work by disrupting balance of cellular signals
5. Targeted melanoma education of high risk groups improves screening
6. Targeted lymph node examination improves staging of colon cancer
7. Targeted cancer drug combined with low-dose chemotherapy shrinks tumors, slows ovarian cancer
8. Chemotherapy with bevacizumab increases risk of blood clots in arteries
9. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
10. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
11. Hormone therapy offers new hope for ovarian cancer patients

Post Your Comments:
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world leader in ... its award-winning print and artwork inspection solutions, ScanProof and ArtProof at Packaging ... the Olympia London, booth #F33 , Be the first to get a sneak peek ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes Carol ... announce the additional of Carol Wysham, MD, to their esteemed Board of Directors. ... Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson and ...
(Date:9/3/2015)... ... September 03, 2015 , ... ProScrub is a set of ... forth, flicker, repeat, and custom speed effects without the use of keyframes. Utilize ... effect. ProScrub tools are perfect complements to energetic video productions. ProScrub is ...
(Date:9/3/2015)... ... September 03, 2015 , ... AvePoint, the established leader ... Service Pack (SP) 4 – AvePoint’s solution for facilitating two-way collaboration and external ... 2015 Trend-Setting Product”. This is the fifth consecutive year an AvePoint product has ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... team will be participating at the highly anticipated Mississippi Gulf Babypalooza on September ... coming from all over, from Gulfport, Biloxi, and beyond. We will be discussing ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) has announced ... Market - By Packaging type, Regions and Vendors - ... to their offering. The growth of ... end use industry, i.e., Medical devices industry. More innovations ... so as to be tamper evident, and child-resistant. The ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/tzzq39/investigation ) ... on China,s Trastuzumab Market, 2010-2019" report to their ... by FDA to be used in the clinic in ... major product of Roche. In 2013, the sales value ... After entering China in ...
(Date:9/3/2015)... China,s startup business ... a wearable medical device that can continuously monitor the ... safety guidance for pregnant women. The device will debut ... which measures 4 centimeters in diameter, is as thin ... than an Apple earphone cord. The small and compact ...
Breaking Medicine Technology:Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2
Cached News: